Last edition
News about "German generics firm Stada Arzneimittel"
Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve
Stada and its owners are also considering alternative ownership options, including a potential sale. The company previously held talks with private equity firm CapVest, which would have valued Stada at around 10 billion euro including debt. Those discussions have since stalled, prompting a stronger push toward the IPO route.
German Generics Firm Stada Arzneimittel | 29/08/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy